129 related articles for article (PubMed ID: 3474046)
1. Assessment of serum CA 19.9 as a tumour marker in patients with carcinoma of the bladder and prostate.
Abel PD; Cornell C; Buamah PK; Williams G
Br J Urol; 1987 May; 59(5):427-9. PubMed ID: 3474046
[TBL] [Abstract][Full Text] [Related]
2. The use of CA-50 radioimmunoassay test in diagnosis of urologic malignancy. Tie for second place Jobst award.
Hershman MJ; Habib NA; Ferro MA; Williamson RC; Wood CB
Am Surg; 1987 Dec; 53(12):691-4. PubMed ID: 3480697
[TBL] [Abstract][Full Text] [Related]
3. CA-50 as tumour marker in transitional bladder carcinoma.
Tizzani A; Casetta G; Piana P; Piantino P
Br J Urol; 1989 Jun; 63(6):616-8. PubMed ID: 2752254
[TBL] [Abstract][Full Text] [Related]
4. [Blood and urinary values of CEA and CA 19-9 in patients with bladder carcinoma].
Cicigoi A; Rocca Rossetti S; Piantino P; Cerchier A
Minerva Med; 1986 Nov; 77(42-43):1983-7. PubMed ID: 3464851
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies to human prostate and bladder tumor-associated antigens.
Starling JJ; Sieg SM; Beckett ML; Schellhammer PF; Ladaga LE; Wright GL
Cancer Res; 1982 Aug; 42(8):3084-9. PubMed ID: 7046915
[TBL] [Abstract][Full Text] [Related]
6. [Behavior of ABH surface antigens in superficial and invasive bladder neoplasma: inferences for the mechanism of tumor progression].
Srougi M; Alves VA; Gayotto LC; Arap S
Rev Hosp Clin Fac Med Sao Paulo; 1986; 41(1):24-7. PubMed ID: 3547591
[No Abstract] [Full Text] [Related]
7. Cell surface antigen -- a study in bladder tumours.
Kulkarni JN; Kamat MR; Gangal SG; Talwalkar GV
J Surg Oncol; 1982 Jan; 19(1):14-17. PubMed ID: 7057638
[TBL] [Abstract][Full Text] [Related]
8. [Conservation or loss of membrane antigens of the ABH blood group and their precursor substance. Prognostic importance for tumors of the bladder].
Hammou JC; Fella C; Vacant J
Acta Urol Belg; 1983; 51(1):12-7. PubMed ID: 6858793
[No Abstract] [Full Text] [Related]
9. Cell surface antigens of human bladder tumors: definition of tumor subsets by monoclonal antibodies and correlation with growth characteristics.
Fradet Y; Cordon-Cardo C; Whitmore WF; Melamed MR; Old LJ
Cancer Res; 1986 Oct; 46(10):5183-8. PubMed ID: 3756873
[TBL] [Abstract][Full Text] [Related]
10. Tumor markers in bladder cancer.
Huben RP
Urology; 1984 Mar; 23(3 Suppl):10-4. PubMed ID: 6367189
[No Abstract] [Full Text] [Related]
11. Epithelial markers in prostatic, bladder, and colorectal cancer: an immunoperoxidase study of epithelial membrane antigen, carcinoembryonic antigen, and prostatic acid phosphatase.
Heyderman E; Brown BM; Richardson TC
J Clin Pathol; 1984 Dec; 37(12):1363-9. PubMed ID: 6392348
[TBL] [Abstract][Full Text] [Related]
12. The clinical significance of pre-operative serum CA 125 in ovarian cancer.
Cruickshank DJ; Fullerton WT; Klopper A
Br J Obstet Gynaecol; 1987 Jul; 94(7):692-5. PubMed ID: 2441738
[TBL] [Abstract][Full Text] [Related]
13. Origin of carcinomas causing bladder neck obstruction demonstrated by immunoperoxidase localisation of specific antigens.
Al Adnani MS
Br J Urol; 1986 Jun; 58(3):283-6. PubMed ID: 3521781
[TBL] [Abstract][Full Text] [Related]
14. Tumour-associated antigen CA 125 in patients with ovarian cancer.
Heinonen PK; Tontti K; Koivula T; Pystynen P
Br J Obstet Gynaecol; 1985 May; 92(5):528-31. PubMed ID: 3857939
[TBL] [Abstract][Full Text] [Related]
15. Double blind comparison of T-antigen and ABO(H) cell surface antigens in bladder cancer.
Vafier JA; Javadpour N; Worsham GF; O'Connell KJ
Urology; 1984 Apr; 23(4):348-51. PubMed ID: 6369713
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic evaluation of patients with cancer of the bladder by detection of ABH surface antigens].
Srougi M; Alves VA; Gayotto LC; Raia S; Arap S
AMB Rev Assoc Med Bras; 1987; 33(3-4):67-70. PubMed ID: 3501142
[No Abstract] [Full Text] [Related]
17. Immunocytochemical localisation of prostate-specific antigen: specificity and application to clinical practice.
Ford TF; Butcher DN; Masters JR; Parkinson MC
Br J Urol; 1985 Feb; 57(1):50-5. PubMed ID: 2578846
[TBL] [Abstract][Full Text] [Related]
18. [Immunofluorescence study of the distribution of ABH cell surface antigens in bladder tumours (author's transl)].
Vallancien G; Rouger P; Leclerc JP; Kuss R
Sem Hop; 1982 May; 58(19):1161-4. PubMed ID: 6285497
[TBL] [Abstract][Full Text] [Related]
19. Cell surface antigen in bilharzial bladder tumours.
Halim A; Javadpour N; Kasraeian A; Young JD
Br J Urol; 1986 Oct; 58(5):523-5. PubMed ID: 3096417
[TBL] [Abstract][Full Text] [Related]
20. The cell surface antigens of bladder washing specimens in patients with bladder tumors, a new approach.
Sadoughi N; Rubenstone A; Mlsna J; Davidsohn I
J Urol; 1980 Jan; 123(1):19-21. PubMed ID: 6985978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
